Paratus Sciences Appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officer
February 21, 2024 07:00 ET
|
Paratus Sciences Corporation
Paratus Sciences Corporation appoints Theresa Heah, M.D., M.B.A. as Chief Executive Officer and a member of its Board of Directors.
Brusco Vision Shares Article on Cost of RLE Surgery
February 20, 2024 13:43 ET
|
Brusco Vision
Falls Church, Virginia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- In the evolving landscape of vision correction, Brusco Vision emerges as a beacon of innovation and patient-centric care, particularly in...
Brinton Vision Offers Breakthrough Solutions for Presbyopia – Transforming Vision After 40
February 20, 2024 13:25 ET
|
Brinton Vision
St. Louis, Missouri, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Brinton Vision, a leader in advanced vision correction, announces groundbreaking solutions for individuals struggling with presbyopia, a...
AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
February 20, 2024 09:00 ET
|
AXIM Biotechnologies, Inc.
The Company’s Commercialization Partner Verséa Ophthalmic Places Re-stock Order of AXIM’s Digital Assay Reader SAN DIEGO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – AXIM...
Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
February 20, 2024 09:00 ET
|
Waldencast plc.
LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare, is thrilled to announce the...
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
February 20, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, will report its fourth quarter and full year 2023...
RetinAI Discovery® platform and AI tools launched to improve decision workflows, referrals and patient management in Clinics for Ophthalmologists and Optometrists
February 20, 2024 03:00 ET
|
RetinAI US Inc
BERN, Switzerland and BOSTON, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ikerian AG and RetinAI Inc. US (“RetinAI”), a leader in developing software solutions for image processing and artificial intelligence...
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor
February 19, 2024 18:25 ET
|
Opthea Limited
MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly...
Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
February 19, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Gene Therapies In Ophthalmology Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Global Intraocular Lens Market Size, Trends and Forecasts Report, 2023 and 2024-2030 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss Meditec, Novartis
February 19, 2024 04:05 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Intraocular Lens Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...